R-Pharm
Sign in to saveAlso known as R-Pharm (Russia)
thumb|right|R-Pharm logo R-Pharm () is an international pharmaceutical company headquartered in Russia. It reached the headlines in September 2020 following approval of its drug "Coronavir" as a treatment in cases of mild to moderate COVID-19 infection. It was founded by Alexey Repik (ru) in 2001, but has had an increasingly international operations base since, with Japanese Corporation Mitsui & Co., Ltd. acquiring 10% of its shares in 2017. In 2022, against the background of the introduction of personal sanctions, Alexey Repik resigned from the owners of R-Pharm, selling his share in the comp
Research organization · ROR
- Type
- Company
- Founded
- 2011
- Location
- Moscow, Russia
- Status
- Active
GRID grid.476664.1
Wikidata facts
- Instance of
- pharmaceutical company
- Official name
- АО Р-Фарм
- Country
- Russia
- Headquarters
- Moscow
- Industry
- pharmaceutical industry
- Employees
- 3600
- Revenue
- 56724200000
- Legal form
- closed joint-stock company
- Official website
- www.r-pharm.com/ru
Show 3 more facts
- street address
- Ленинский проспект, д.111Б, 119421 г. Москва
- inception
- 2001-00-00
- on focus list of Wikimedia project
- WikiProject COVID-19
Sources (11)
via Wikidata · CC0
~4 min read
Encyclopedic overview
5 sectionsContents
- Activity
- COVID-19
- See also
- Notes
- References
thumb|right|R-Pharm logo R-Pharm () is an international pharmaceutical company headquartered in Russia. It reached the headlines in September 2020 following approval of its drug "Coronavir" as a treatment in cases of mild to moderate COVID-19 infection. It was founded by Alexey Repik (ru) in 2001, but has had an increasingly international operations base since, with Japanese Corporation Mitsui & Co., Ltd. acquiring 10% of its shares in 2017. In 2022, against the background of the introduction of personal sanctions, Alexey Repik resigned from the owners of R-Pharm, selling his share in the company to the management of R-Pharm, and resigned as chairman of the board of directors.
==Activity== The company's scope of activities covers areas related to the development, research, production, marketing of drugs intended primarily for inpatient and specialized medical care. The main areas of activity are: production of finished dosage forms, active pharmaceutical ingredients of chemical nature and biotechnological substances, research and development of drugs and technologies, introduction to the Russian market of pharmaceuticals.
Excerpted from Wikipedia’s “R-Pharm” article, available under the CC BY-SA 4.0 licence.